Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: pathology

Tamtron Plans Comeback After IMPATH’s Chapt. 11

CEO SUMMARY: It was only 21 months ago that IMPATH acquired Tamtron. Both companies had high expectations for the relationship. But with IMPATH now in Chapter 11 bankruptcy and facing an unclear future, Tamtron is now an attractive asset for potential buyers who want to enter the anatomic pathology marketplace with an established product like …

Tamtron Plans Comeback After IMPATH’s Chapt. 11 Read More »

To access this post, you must purchase The Dark Report.

Market Demand for Pathologists Shifts Toward Specialization

CEO SUMMARY: Unlike the slack employment market for pathologists seen during the 1990s, there is strong demand for pathologists in this decade. Private pathology group practices now face competition for the best pathology talent. That’s because public lab companies are regularly in the marketplace looking to hire pathologists with the right subspecialty skills and expertise. …

Market Demand for Pathologists Shifts Toward Specialization Read More »

To access this post, you must purchase The Dark Report.

Mergers Create Two Huge National Health Insurers

ANOTHER ROUND OF CONSOLIDATION among health insurers has created a new “biggest in the nation” company and boosted the size of the second largest health insurance company. On October 28, in separate announcements that were just 30 minutes apart, Anthem Inc. disclosed it would pay $14.2 billion to acquire WellPoint Health Networks Inc. and United …

Mergers Create Two Huge National Health Insurers Read More »

To access this post, you must purchase The Dark Report.

“November 10, 2003 Intelligence: Late Breaking Lab News”

Has the disappearance of much despised closed panel HMOs eased the financial woes of physicians? Apparently not, according to a recent study. Medical groups are losing money. Nationwide, the average loss-per-physician by medical groups was $3,977. In the 2003 survey, 25,784 physicians responded, a 26% increase from 2002. The study was conducted jointly by the …

“November 10, 2003 Intelligence: Late Breaking Lab News” Read More »

To access this post, you must purchase The Dark Report.

No Disruptive Technology In Lab Industry’s Future

CEO SUMMARY: As new diagnostic technologies move through the development pipeline and into widespread clinical use, the scientific knowledge and skill sets needed by laboratory staff and management will change. The emphasis in laboratory medicine will evolve to include more molecular technology, but this evolution will proceed incrementally, giving all laboratories time to adapt. RAPID …

No Disruptive Technology In Lab Industry’s Future Read More »

To access this post, you must purchase The Dark Report.

Looking at Fast-Growth And Slow-Growth Areas In Diagnostic Testing

CEO SUMMARY: This exclusive intelligence briefing predicts how specific new technologies may drive changes in the laboratory-testing marketplace during the next five years. The key message is that change is expected to be incremental, not disruptive—given the technology known to be in development at this time. But the more provocative insight relates to how even …

Looking at Fast-Growth And Slow-Growth Areas In Diagnostic Testing Read More »

To access this post, you must purchase The Dark Report.

Two Blood Brothers Ramp Up Marketing of New Lab Assays

GROWTH IN SPECIMEN VOLUME and revenues is the major challenge at the nation’s two largest laboratory corporations. How Laboratory Corporation of America and Quest Diagnostics Incorporated solve this problem will affect and influence every remaining clinical laboratory and pathology group practice in the United States. That’s because the marketing and pricing strategies of the two …

Two Blood Brothers Ramp Up Marketing of New Lab Assays Read More »

To access this post, you must purchase The Dark Report.

Chapter 11 Bankruptcy Filed by IMPATH, Inc.

CEO SUMMARY: To the surprise of very few, IMPATH, Inc. filed for Chapter 11 bankruptcy protection. During 2003, most of IMPATH’s key executives departed as different problems within the company became known. IMPATH’s new executive leadership is dealing with a host of difficult issues. Caught up in this situation is Tamtron, the division of IMPATH …

Chapter 11 Bankruptcy Filed by IMPATH, Inc. Read More »

To access this post, you must purchase The Dark Report.

AP’s “High & Mighty” Firms Hit Tough Times

CEO SUMMARY: In the years between 1995 and 2002, public companies AmeriPath, DIANON Systems, and IMPATH built revenues and profits at a blistering pace. During this time period, these three firms captured enough market share to do almost $1 billion of anatomic pathology business in 2002. But that run of business success has ended. Each …

AP’s “High & Mighty” Firms Hit Tough Times Read More »

To access this post, you must purchase The Dark Report.

Entrepreneur Offers Private Pay Autopsies

CEO SUMMARY: For the past 14 years, a non-pathologist entrepreneur has enjoyed a growing business in offering autopsy services to clients willing to pay out-of-pocket. By design, the business is limited to the Southern California region. But demand in that region is enough to regularly engage the autopsy services of six pathologists. Here’s a look …

Entrepreneur Offers Private Pay Autopsies Read More »

To access this post, you must purchase The Dark Report.

;